检索结果 - Xing-Fu Li
- Showing 1 - 3 results of 3
-
1
SAT0218 Efficacy and safety of baricitinib in mtx-ir patients with rheumatoid arthritis: 52 week results from a phase 3 study (RA-BALANCE) 由 Zhijun Li, Jian Hu, Chunde Bao, Xing‐Fu Li, Xiaoling Li, Jing Xu, Alberto Spindler, Xiao Zhang, Jing Xu, Zhijun Li, G. Wang, Jiao Sun, Fei Ji, Hong Tao, Lixia Zhan, Terence Rooney, Cristiano A. F. Zerbini
出版 2018Artigo -
2
Efficacy and Safety of Baricitinib in Chinese Rheumatoid Arthritis Patients and the Subgroup Analyses: Results from Study RA-BALANCE 由 Yue Yang, Xing-Fu Li, Xiao Zhang, Chunde Bao, Jiankang Hu, Jianhua Xu, Xiang-Pei Li, Jian Xu, Dongyi He, Zhijun Li, Guochun Wang, Han‐Jun Wu, Fei Ji, Lujing Zhan, Cristiano A. F. Zerbini, Zhanguo Li
出版 2020Artigo -
3
A multicenter, double-blind, randomized, controlled phase III clinical trial of chicken type II collagen in rheumatoid arthritis 由 Wei Wei, Lingling Zhang, Jian-hua Xu, Feng Xiao, Chun-De Bao, Li‐Qing Ni, Xing-Fu Li, Yu-Qing Wu, Ling-Yun Sun, Rong-Hua Zhang, Bao-Liang Sun, Sheng-Qian Xu, Shang Liu, Wei Zhang, Jie Shen, Huaxiang Liu, Ren-Cheng Wang
出版 2009Artigo
相关主题
Internal medicine
Medicine
Methotrexate
Rheumatoid arthritis
Alternative medicine
Clinical endpoint
Clinical trial
Gastroenterology
Pathology
Physical therapy
Placebo
Randomized controlled trial
Rheumatology
Adverse effect
Arthritis
C-reactive protein
Erythrocyte sedimentation rate
Inflammation
Janus kinase inhibitor
Joint pain
Phases of clinical research
Rheumatoid factor
Surgery
Tofacitinib